Related Experiment Video

Updated: Jun 20, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Tumor suppression by LKB1: SIK-ness prevents metastasis

Reuben J Shaw1

  • 1Molecular and Cell Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA. shaw@salk.edu

Science Signaling
|September 3, 2009
PubMed

Insights

The tumor suppressor LKB1 kinase is crucial for preventing cancer. Its newly identified target, salt-inducible kinase 1 (SIK1), regulates cell death and metastasis, offering potential therapeutic targets for cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The LKB1 serine-threonine kinase acts as a tumor suppressor, frequently inactivated in lung non-small cell carcinomas (NSCLCs) and cervical cancers.
  • Loss of LKB1 function promotes tumorigenesis and metastasis in preclinical models.
  • LKB1 regulates cell metabolism, growth, and polarity through a network of 14 downstream kinases, but their specific roles in tumor suppression are unclear.

Purpose of the Study:

  • To investigate the role of LKB1-regulated kinases in tumor suppression.
  • To identify specific LKB1 targets critical for controlling anoikis and metastasis.
  • To evaluate the therapeutic potential of targeting LKB1-dependent pathways.

Main Methods:

  • Utilized mouse models of LKB1 deletion to study tumorigenesis and metastasis.
  • Investigated the function of LKB1-dependent kinases, focusing on salt-inducible kinase 1 (SIK1).
  • Assessed the impact of SIK1 on anoikis, cell transformation, and p53 modulation in vitro and in vivo.
  • Correlated SIK1 expression with patient prognosis using human breast cancer datasets.

Main Results:

  • Identified SIK1 as a key LKB1-dependent kinase modulating anoikis and cellular transformation.
  • Demonstrated that SIK1 regulates the tumor suppressor p53, controlling metastasis in transplanted tumors.
  • Found reduced SIK1 expression correlated with poor prognosis in human breast cancer patients.
  • SIK1 emerges as a critical regulator of p53-dependent anoikis.

Conclusions:

  • SIK1 is a crucial downstream effector of the LKB1 tumor suppressor.
  • SIK1's regulation of p53-dependent anoikis highlights its role in preventing cancer progression and metastasis.
  • Targeting SIK1 represents a potential therapeutic strategy for cancers with LKB1 inactivation.

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...